News Daily News SOCRATES: Ticagrelor No Supera a la Aspirina en Prevención Secundaria Post ACV-AIT Todd Neale May 11, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Daily News Statins Tied to Lower Mortality, Amputation Risks in PAD Michael O'Riordan May 09, 2016
News Daily News STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased Michael O'Riordan May 05, 2016
News Conference News SCAI 2016 Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding L.A. McKeown May 05, 2016
News Features Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent Michael O'Riordan May 03, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados Yael L. Maxwell April 25, 2016
News Daily News Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows Michael O'Riordan April 14, 2016
News Daily News USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals Michael O'Riordan April 12, 2016
News Daily News El USPSTF Refuerza las Recomendaciones en materia de Prevención Primaria al asegurar que la Aspirina Solo Debería de Emplearse en Sujetos de Riesgo Alto Michael O'Riordan April 12, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9 Michael O'Riordan April 02, 2016
News Daily News Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES Yael L. Maxwell March 30, 2016
News Daily News Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF Yael L. Maxwell March 30, 2016